Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Combined therapies in scar treatment-The role of autologous derived agents in scar remodeling: A series of cases.

Surowiecka A.

Laboratory Study on Scar, published in Dermatol Ther (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Dermatol Ther (2022)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
36181298
DOI
10.1111/dth.15877
Citations
6

Abstract (original English)

Comprehensive scar treatment usually requires a combination of several methods. The selection of methods should depend on the appearance and biology of the scar. The aim of this study was to determine the safety and efficiency of combined methods with the use of autologous derived agents in the treatment of scars, based on the available literature and own experience. The study consists of a description of three cases treated with autologous derived agents: platelet-rich plasma (PRP), lipofilling or stromal vascular fraction (SVF) in combination with radiofrequency, CO 2 laser, or cutting threads. No adverse events were reported. Improvement in scar quality and function was observed in all cases. Combination of autologous derived injectables with medical devices is safe and accelerates both cosmetic and functional results.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansCicatrixLasers, GasPlatelet-Rich PlasmaTransplantation, AutologousTreatment Outcome

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research